Advanced search
Publication Cover
Expert Opinion on Biological Therapy Volume 9, 2009 - Issue 4
Submit an article Journal homepage
139
Views
1
CrossRef citations to date
0
Altmetric
Reviews

Oligonucleotide based-strategies for allergy with special reference to siRNA

Motohiko Suzuki University of Western Ontario, University Hospital C9 – 136, Departments of Surgery, Pathology and Oncology, 339 Windermere Road, London, Ontario, N6A 5A5, Canada +1 519 663 2985; +1 519 663 3295; [email protected]; Nagoya City University, Department of Otorhinolaryngology, Nagoya, Japan
,
Xiufen Zheng University of Western Ontario, University Hospital C9 – 136, Departments of Surgery, Pathology and Oncology, 339 Windermere Road, London, Ontario, N6A 5A5, Canada +1 519 663 2985; +1 519 663 3295; [email protected]
,
Xusheng Zhang University of Western Ontario, University Hospital C9 – 136, Departments of Surgery, Pathology and Oncology, 339 Windermere Road, London, Ontario, N6A 5A5, Canada +1 519 663 2985; +1 519 663 3295; [email protected]
,
Thomas E Ichim University of Western Ontario, University Hospital C9 – 136, Departments of Surgery, Pathology and Oncology, 339 Windermere Road, London, Ontario, N6A 5A5, Canada +1 519 663 2985; +1 519 663 3295; [email protected]; Medistem Laboratories, San Diego, CA, USA
,
Marianne E Beduhn University of Western Ontario, University Hospital C9 – 136, Departments of Surgery, Pathology and Oncology, 339 Windermere Road, London, Ontario, N6A 5A5, Canada +1 519 663 2985; +1 519 663 3295; [email protected]
&
Weiping Min University of Western Ontario, University Hospital C9 – 136, Departments of Surgery, Pathology and Oncology, 339 Windermere Road, London, Ontario, N6A 5A5, Canada +1 519 663 2985; +1 519 663 3295; [email protected]
Pages 441-450 | Published online: 03 Apr 2009

Bibliography

  • Poulsen LK, Hummelshoj L. Triggers of IgE class switching and allergy development. Ann Med 2007;39:440-56
  • Bacharier LB, Geha RS. Molecular mechanisms of IgE regulation. J Allergy Clin Immunol 2000;105:S547-58
  • Jelinek DF. Regulation of B lymphocyte differentiation. Ann Allergy Asthma Immunol 2000;84:375-85; quiz 385-7
  • Hamelmann E, Gelfand EW. IL-5-induced airway eosinophilia–the key to asthma? Immunol Rev 2001;179:182-91
  • Shi H, Qin S, Huang G, et al. Infiltration of eosinophils into the asthmatic airways caused by interleukin 5. Am J Respir Cell Mol Biol 1997;16:220-4
  • Shi HZ, Xiao CQ, Zhong D, et al. Effect of inhaled interleukin-5 on airway hyperreactivity and eosinophilia in asthmatics. Am J Respir Crit Care Med 1998;157:204-9
  • Foster PS, Hogan SP, Ramsay AJ, et al. Interleukin 5 deficiency abolishes eosinophilia, airways hyperreactivity, and lung damage in a mouse asthma model. J Exp Med 1996;183:195-201
  • Corrigan CJ, Kay AB. T cells and eosinophils in the pathogenesis of asthma. Immunol Today 1992;13:501-7
  • Nishioka K, Saito C, Nagano T, et al. Eosinophil cationic protein in the nasal secretions of patients with mite allergic rhinitis. Laryngoscope 1993;103:189-92
  • Belvisi MG, Hele DJ, Birrell MA. New anti-inflammatory therapies and targets for asthma and chronic obstructive pulmonary disease. Expert Opin Ther Targets 2004;8:265-85
  • Senti G, Prinz Vavricka BM, Erdmann I, et al. Intralymphatic allergen administration renders specific immunotherapy faster and safer: a randomized controlled trial. Proc Natl Acad Sci USA 2008;105:17908-12
  • Tong AW, Zhang YA, Nemunaitis J. Small interfering RNA for experimental cancer therapy. Curr Opin Mol Ther 2005;7:114-24
  • Bertrand JR, Pottier M, Vekris A, et al. Comparison of antisense oligonucleotides and siRNAs in cell culture and in vivo. Biochem Biophys Res Commun 2002;296:1000-4
  • Thompson JD. Applications of antisense and siRNAs during preclinical drug development. Drug Discov Today 2002;7:912-7
  • Tsalik EL. DNA-based immunotherapy to treat atopic disease. Ann Allergy Asthma Immunol 2005;95:403-10; quiz 410-411, 451
  • Fonseca DE, Kline JN. Use of CpG oligonucleotides in treatment of asthma and allergic disease. Adv Drug Deliv Rev 2009, published online 9 January 2009 doi:10.1016/j.addr.2008.12.007
  • Shirota H, Sano K, Hirasawa N, et al. Novel roles of CpG oligodeoxynucleotides as a leader for the sampling and presentation of CpG-tagged antigen by dendritic cells. J Immunol 2001;167:66-74
  • Tulic MK, Fiset PO, Christodoulopoulos P, et al. Amb a 1-immunostimulatory oligodeoxynucleotide conjugate immunotherapy decreases the nasal inflammatory response. J Allergy Clin Immunol 2004;113:235-41
  • Creticos PS, Schroeder JT, Hamilton RG, et al. Immunotherapy with a ragweed-toll-like receptor 9 agonist vaccine for allergic rhinitis. N Engl J Med 2006;355:1445-55
  • Gauvreau GM, Hessel EM, Boulet LP, et al. Immunostimulatory sequences regulate interferon-inducible genes but not allergic airway responses. Am J Respir Crit Care Med 2006;174:15-20
  • An Evaluation of the efficacy and safety of Tolamba™ for ragweed-allergic rhinitis in an environmental exposure chamber. National Institute of Health. Bethesda, MD: 2008; Available from: http://clinicaltrials.gov/ct2/show/NCT00537355?term=NCt00537355&rank=1
  • Kozak W, Wrotek S, Kozak A. Pyrogenicity of CpG-DNA in mice: role of interleukin-6, cyclooxygenases and nuclear factor-κB. Am J Physiol Regul Integr Comp Physiol 2006;290:R871-80
  • Nichani AK, Dar MA, Krieg AM, et al. Systemic innate immune responses following intrapulmonary delivery of CpG oligodeoxynucleotides in sheep. Vet Immunol Immunopathol 2007;115:357-68
  • Nichani AK, Mena A, Popowych Y, et al. In vivo immunostimulatory effects of CpG oligodeoxynucleotide in cattle and sheep. Vet Immunol Immunopathol 2004;98:17-29
  • Segal BM, Klinman DM, Shevach EM. Microbial products induce autoimmune disease by an IL-12-dependent pathway. J Immunol 1997;158:5087-90
  • Zimmermann S, Heeg K, Dalpke A. Immunostimulatory DNA as adjuvant: efficacy of phosphodiester CpG oligonucleotides is enhanced by 3′ sequence modifications. Vaccine 2003;21:990-5
  • Bartz H, Mendoza Y, Gebker M, et al. Poly-guanosine strings improve cellular uptake and stimulatory activity of phosphodiester CpG oligonucleotides in human leukocytes. Vaccine 2004;23:148-55
  • Chiang DJ, Ye YL, Chen WL, et al. Ribavirin or CpG DNA sequence-modulated dendritic cells decrease the IgE level and airway inflammation. Am J Respir Crit Care Med 2003;168:575-80
  • Trujillo-Vargas CM, Ramirez-Pineda JR, Palmetshofer A, et al. Mice vaccinated with allergen-pulsed myeloid dendritic cells are not protected from developing allergen-induced Th2 responses. Int Arch Allergy Immunol 2005;137:219-28
  • Larche M, Wraith DC. Peptide-based therapeutic vaccines for allergic and autoimmune diseases. Nat Med 2005;11:S69-76
  • Norman PS. Immunotherapy: 1999-2004. J Allergy Clin Immunol 2004;113:1013-23; quiz 1024
  • Tarzi M, Klunker S, Texier C, et al. Induction of interleukin-10 and suppressor of cytokine signalling-3 gene expression following peptide immunotherapy. Clin Exp Allergy 2006;36:465-74
  • Alexander C, Tarzi M, Larche M, Kay AB. The effect of Fel d 1-derived T-cell peptides on upper and lower airway outcome measurements in cat-allergic subjects. Allergy 2005;60:1269-74
  • Suzuki M, Ohta N, Min WP, et al. Immunotherapy with CpG DNA conjugated with T-cell epitope peptide of an allergenic Cry j 2 protein is useful for control of allergic conditions in mice. Int Immunopharmacol 2007;7:46-54
  • Lebedeva I, Stein CA. Antisense oligonucleotides: promise and reality. Annu Rev Pharmacol Toxicol 2001;41:403-19
  • Gauvreau GM, Boulet LP, Cockcroft DW, et al. Antisense therapy against CCR3 and the common beta chain attenuates allergen-induced eosinophilic responses. Am J Respir Crit Care Med 2008;177:952-8
  • Fire A, Xu S, Montgomery MK, et al. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 1998;391:806-11
  • Voinnet O. Induction and suppression of RNA silencing: insights from viral infections. Nat Rev Genet 2005;6:206-20
  • Ullu E, Djikeng A, Shi H, Tschudi C. RNA interference: advances and questions. Philos Trans R Soc Lond B Biol Sci 2002;357:65-70
  • Waterhouse PM, Wang MB, Lough T. Gene silencing as an adaptive defence against viruses. Nature 2001;411:834-42
  • Elbashir SM, Harborth J, Lendeckel W, et al. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 2001;411:494-8
  • Proud CG. PKR: a new name and new roles. Trends Biochem Sci 1995;20:241-6
  • Adah SA, Bayly SF, Cramer H, et al. Chemistry and biochemistry of 2′,5′-oligoadenylate-based antisense strategy. Curr Med Chem 2001;8:1189-212
  • Williams BR. Signal integration via PKR. Sci STKE 2001;2001:RE2, published online 3 July 2001, doi: 10.1126/stke.2001.89.re2
  • Saunders LR, Barber GN. The dsRNA binding protein family: critical roles, diverse cellular functions. FASEB J 2003;17:961-83
  • Schlee M, Hornung V, Hartmann G. siRNA and isRNA: two edges of one sword. Mol Ther 2006;14:463-70
  • Timmons L. The long and short of siRNAs. Mol Cell 2002;10:435-7
  • Zheng X, Zhang X, Sun H, et al. Protection of renal ischemia injury using combination gene silencing of complement 3 and caspase 3 genes. Transplantation 2006;82:1781-6
  • Zheng X, Zhang X, Feng B, et al. Gene silencing of complement C5a receptor using siRNA for preventing ischemia/reperfusion injury. Am J Pathol 2008;173:973-80
  • Zhang X, Zheng X, Sun H, et al. Prevention of renal ischemic injury by silencing the expression of renal caspase 3 and caspase 8. Transplantation 2006;82:1728-32
  • Scherr M, Battmer K, Winkler T, et al. Specific inhibition of bcr-abl gene expression by small interfering RNA. Blood 2003;101:1566-9
  • Choudhury A, Charo J, Parapuram SK, et al. Small interfering RNA (siRNA) inhibits the expression of the Her2/neu gene, upregulates HLA class I and induces apoptosis of Her2/neu positive tumor cell lines. Int J Cancer 2004;108:71-7
  • Martinez LA, Naguibneva I, Lehrmann H, et al. Synthetic small inhibiting RNAs: efficient tools to inactivate oncogenic mutations and restore p53 pathways. Proc Natl Acad Sci USA 2002;99:14849-54
  • Palliser D, Chowdhury D, Wang QY, et al. An siRNA-based microbicide protects mice from lethal herpes simplex virus 2 infection. Nature 2006;439:89-94
  • Ji J, Wernli M, Klimkait T, Erb P. Enhanced gene silencing by the application of multiple specific small interfering RNAs. FEBS Lett 2003;552:247-52
  • Rossi JJ, June CH, Kohn DB. Genetic therapies against HIV. Nat Biotechnol 2007;25:1444-54
  • de Fougerolles A, Vornlocher HP, Maraganore J, Lieberman J. Interfering with disease: a progress report on siRNA-based therapeutics. Nat Rev Drug Discov 2007;6:443-53
  • Hoey T, Grusby MJ. STATs as mediators of cytokine-induced responses. Adv Immunol 1999;71:145-62
  • Kaplan MH, Schindler U, Smiley ST, Grusby MJ. Stat6 is required for mediating responses to IL-4 and for development of Th2 cells. Immunity 1996;4:313-9
  • Kozma N, Halasz M, Polgar B, et al. Progesterone-induced blocking factor activates STAT6 via binding to a novel IL-4 receptor. J Immunol 2006;176:819-26
  • Zhu J, Min B, Hu-li J, et al. Conditional deletion of Gata3 shows its essential function in TH1-TH2 responses. Nat Immunol 2004;5:1157-65
  • Ferber IA, Lee HJ, Zonin F, et al. GATA-3 significantly downregulates IFN-γ production from developing Th1 cells in addition to inducing IL-4 and IL-5 levels. Clin Immunol 1999;91:134-44
  • Lee HJ, O'Garra A, Arai K, Arai N. Characterization of cis-regulatory elements and nuclear factors conferring Th2-specific expression of the IL-5 gene: a role for a GATA-binding protein. J Immunol 1998;160:2343-52
  • Maneechotesuwan K, Xin Y, Ito K, et al. Regulation of Th2 cytokine genes by p38 MAPK-mediated phosphorylation of GATA-3. J Immunol 2007;178:2491-8
  • Lee CC, Huang HY, Chiang BL. Lentiviral-mediated GATA-3 RNAi decreases allergic airway inflammation and hyperresponsiveness. Mol Ther 2008;16:60-5
  • Huang HY, Lee CC, Chiang BL. Small interfering RNA against interleukin-5 decreases airway eosinophilia and hyper-responsiveness. Gene Ther 2008;15:660-7
  • Suzuki M, Zheng X, Zhang X, et al. Novel vaccination for allergy through gene silencing of CD40 using small interfering RNA. J Immunol 2008;180:8461-9
  • Caux C, Massacrier C, Vanbervliet B, et al. Activation of human dendritic cells through CD40 cross-linking. J Exp Med 1994;180:1263-72
  • Peng X, Kasran A, Warmerdam PA, et al. Accessory signaling by CD40 for T cell activation: induction of Th1 and Th2 cytokines and synergy with interleukin-12 for interferon-γ production. Eur J Immunol 1996;26:1621-7
  • Kirk AD, Blair PJ, Tadaki DK, et al. The role of CD154 in organ transplant rejection and acceptance. Philos Trans R Soc Lond B Biol Sci 2001;356:691-702
  • Lanschuetzer CM, Olasz EB, Lazarova Z, Yancey KB. Transient anti-CD40L co-stimulation blockade prevents immune responses against human bullous pemphigoid antigen 2: implications for gene therapy. J Invest Dermatol 2008, published online 27 November 2008, doi: 10.1038/jid.2008.364
  • Blazar BR, Taylor PA, Panoskaltsis-Mortari A, et al. Blockade of CD40 ligand-CD40 interaction impairs CD4+ T cell-mediated alloreactivity by inhibiting mature donor T cell expansion and function after bone marrow transplantation. J Immunol 1997;158:29-39
  • Pochanke V, Hatak S, Hengartner H, et al. Induction of IgE and allergic-type responses in fur mite-infested mice. Eur J Immunol 2006;36:2434-45
  • Taylor PA, Friedman TM, Korngold R, et al. Tolerance induction of alloreactive T cells via ex vivo blockade of the CD40:CD40L costimulatory pathway results in the generation of a potent immune regulatory cell. Blood 2002;99:4601-9
  • Chen YQ, Shi HZ. CD28/CTLA-4–CD80/CD86 and ICOS–B7RP-1 costimulatory pathway in bronchial asthma. Allergy 2006;61:15-26
  • Ritprajak P, Hashiguchi M, Azuma M. Topical application of cream-emulsified CD86 siRNA ameliorates allergic skin disease by targeting cutaneous dendritic cells. Mol Ther 2008;16:1323-30
  • Lai WQ, Goh HH, Bao Z, et al. The role of sphingosine kinase in a murine model of allergic asthma. J Immunol 2008;180:4323-9
  • Ohbayashi H, Suito H, Takagi K. Compared effects of natriuretic peptides on ovalbumin-induced asthmatic model. Eur J Pharmacol 1998;346:55-64
  • Wang X, Xu W, Mohapatra S, et al. Prevention of airway inflammation with topical cream containing imiquimod and small interfering RNA for natriuretic peptide receptor. Genet Vaccines Ther 2008;6:7, published online 15 February 2008, doi:10.1186/1479-0556-6-7
  • Liang X, Lu L, Chen Z, et al. Administration of dendritic cells transduced with antisense oligodeoxyribonucleotides targeting CD80 or CD86 prolongs allograft survival. Transplantation 2003;76:721-9
  • Li M, Zhang X, Zheng X, et al. Immune modulation and tolerance induction by RelB-silenced dendritic cells through RNA interference. J Immunol 2007;178:5480-7
  • Inaba K, Metlay JP, Crowley MT, et al. Dendritic cells as antigen presenting cells in vivo. Int Rev Immunol 1990;6:197-206
  • Urban BC, Willcox N, Roberts DJ. A role for CD36 in the regulation of dendritic cell function. Proc Natl Acad Sci USA 2001;98:8750-5
  • Norbury CC, Chambers BJ, Prescott AR, et al. Constitutive macropinocytosis allows TAP-dependent major histocompatibility complex class I presentation of exogenous soluble antigen by bone marrow-derived dendritic cells. Eur J Immunol 1997;27:280-8
  • Kato M, Neil TK, Fearnley DB, et al. Expression of multilectin receptors and comparative FITC-dextran uptake by human dendritic cells. Int Immunol 2000;12:1511-9
  • Condon C, Watkins SC, Celluzzi CM, et al. DNA-based immunization by in vivo transfection of dendritic cells. Nat Med 1996;2:1122-8
  • Sullenger BA, Gilboa E. Emerging clinical applications of RNA. Nature 2002;418:252-8
  • Lambrecht BN. Lung dendritic cells: targets for therapy in allergic disease. Curr Mol Med 2008;8:393-400
  • Hammad H, Kool M, Soullie T, et al. Activation of the D prostanoid 1 receptor suppresses asthma by modulation of lung dendritic cell function and induction of regulatory T cells. J Exp Med 2007;204:357-67
  • Lechler R, Ng WF, Steinman RM. Dendritic cells in transplantation–friend or foe? Immunity 2001;14:357-68
  • Steinman RM, Hawiger D, Nussenzweig MC. Tolerogenic dendritic cells. Annu Rev Immunol 2003;21:685-711

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.